Pacira BioSciences, Inc. (PCRX)
CIK 1396814 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Pacira BioSciences, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Nov 5, 2026 | 10-Q | 0001628280-26-071136 |
| Nov 5, 2026 | 8-K | 0001628280-26-071129 |
| Nov 3, 2026 | SC 14D9/A | 0001140361-26-041805 |
| Nov 3, 2026 | 4 | 0001628280-26-069545 |
| Oct 30, 2026 | SCHEDULE 13G/A | 0002100119-26-001682 |
| Oct 30, 2026 | SC 14D9 | 0001140361-26-041229 |
| Oct 30, 2026 | SC TO-T | 0001140361-26-041224 |
| Oct 13, 2026 | SCHEDULE 13D/A | 0001104659-26-115589 |
| Oct 9, 2026 | 4 | 0001628280-26-065566 |
| Oct 8, 2026 | 8-K | 0001104659-26-114571 |
| Oct 8, 2026 | SC TO-C | 0001140361-26-039148 |
| Oct 8, 2026 | 144 | 0001959173-26-007312 |
| Oct 8, 2026 | SC14D9C | 0001104659-26-114706 |
| Oct 8, 2026 | SC TO-C | 0001140361-26-039025 |
| Aug 18, 2026 | 4 | 0001628280-26-057759 |
| Aug 17, 2026 | 144 | 0001959173-26-006073 |
| Aug 7, 2026 | SCHEDULE 13G | 0000093751-26-000517 |
| Aug 4, 2026 | 8-K | 0001628280-26-052527 |
| Aug 4, 2026 | S-8 | 0001628280-26-052724 |
| Aug 4, 2026 | 10-Q | 0001628280-26-052635 |
| Jun 30, 2026 | 8-K | 0001628280-26-046136 |
| Jun 12, 2026 | 4 | 0001628280-26-043004 |
| Jun 12, 2026 | 4 | 0001628280-26-043008 |
| Jun 12, 2026 | 4 | 0001628280-26-043010 |
| Jun 12, 2026 | 4 | 0001628280-26-043007 |